Negative Association Between 15 Obesity- and Lipid-related Indices and Testosterone in Adult Males: a Population Based Cross-sectional Study

Overview

Journal Lipids Health Dis

Publisher Biomed Central

Date 2025 Jan 25

PMID 39863911

Authors

Wei Guo

Shuo Zhao

Qinzheng Chang

Jiajia Sun

Yidong Fan

Jikai Liu

Affiliations

Soon will be listed here.

Abstract

Background: An association exists between obesity and reduced testosterone levels in males. The propose of this research is to reveal the correlation between 15 indices linked to obesity and lipid levels with the concentration of serum testosterone, and incidence of testosterone deficiency (TD) among adult American men.

Methods: The study utilized information gathered from the National Health and Nutrition Examination Survey (NHANES) carried out from 2011 to 2016. The condition known as TD is typically characterized by a total serum testosterone level that falls below 300 ng/dL. The analysis used weighted linear and logistic regression methods to announce the association between 15 obesity- and lipid-related factors and serum testosterone levels as well as TD. Subgroup analyses were further carried out to confirm and validate the findings. Additionally, restricted cubic spline plots were utilized to examine non-linear relationships. Receiver operating characteristic (ROC) curves were created for the 15 factors, and the area under the curves (AUC) was calculated to assess the efficacy of each factor in detecting TD.

Results: Among a group of 3,540 adult males, it was observed that all 15 obesity- and lipid-related indices showed a negative relationship with testosterone concentration and a direct correlation with the presence of TD. After accounting for all covariates, the analysis revealed that individuals within the highest quartile (Q4) for metabolic score for visceral fat (METS-VF) had the excellent probability of developing TD (OR = 13.412, 95%CIs: 4.222, 42.262, P < 0.001). Additionally, a non-linear relationship was detected between the METS-VF with TD. Within the model that incorporated all adjustments, the triglyceride glucose-waist to height ratio (TyG-WHtR) has the best performance for predicting TD (Overall: AUC = 0.762, 95%CIs: 0.743, 0.782, cut-off = 5.186).

Conclusion: Elevated levels of these 15 markers were inversely related to testosterone levels and were indicative of an elevated risk of TD. Among all indices analyzed, TyG-WHtR demonstrated the highest predictive value.

Trial Registration: Not available.

References

Lim J, Kim J, Koo S, Kwon G . Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: An analysis of the 2007-2010 Korean National Health and Nutrition Examination Survey. PLoS One. 2019; 14(3):e0212963. PMC: 6405083. DOI: 10.1371/journal.pone.0212963. View

Host C, Gormsen L, Christensen B, Jessen N, Hougaard D, Christiansen J . Independent effects of testosterone on lipid oxidation and VLDL-TG production: a randomized, double-blind, placebo-controlled, crossover study. Diabetes. 2012; 62(5):1409-16. PMC: 3636625. DOI: 10.2337/db12-0440. View

Ku H, Cheng E, Cheng C . A body shape index (ABSI) but not body mass index (BMI) is associated with prostate cancer-specific mortality: Evidence from the US NHANES database. Prostate. 2024; 84(9):797-806. DOI: 10.1002/pros.24698. View

Kaplan S, Meehan A, Shah A . The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men?. J Urol. 2006; 176(4 Pt 1):1524-7. DOI: 10.1016/j.juro.2006.06.003. View

Liu D, Li Y, Ji N, Xia W, Zhang B, Feng X . Association between weight-adjusted waist index and testosterone deficiency in adult American men: findings from the national health and nutrition examination survey 2013-2016. BMC Public Health. 2024; 24(1):1683. PMC: 11197353. DOI: 10.1186/s12889-024-19202-5. View

Dhindsa S, Ghanim H, Batra M, Kuhadiya N, Abuaysheh S, Sandhu S . Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes. Diabetes Care. 2015; 39(1):82-91. PMC: 4686848. DOI: 10.2337/dc15-1518. View

Muraleedharan V, Jones T . Testosterone and the metabolic syndrome. Ther Adv Endocrinol Metab. 2012; 1(5):207-23. PMC: 3474619. DOI: 10.1177/2042018810390258. View

Muller M . Testosterone and reproductive effort in male primates. Horm Behav. 2016; 91:36-51. PMC: 5342957. DOI: 10.1016/j.yhbeh.2016.09.001. View

Yin H, Guo L, Zhu W, Li W, Zhou Y, Wei W . Association of the triglyceride-glucose index and its related parameters with frailty. Lipids Health Dis. 2024; 23(1):150. PMC: 11107008. DOI: 10.1186/s12944-024-02147-4. View

10.

Vignozzi L, Morelli A, Sarchielli E, Comeglio P, Filippi S, Cellai I . Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit. J Endocrinol. 2011; 212(1):71-84. DOI: 10.1530/JOE-11-0289. View

11.

Santosa S, Jensen M . Effects of male hypogonadism on regional adipose tissue fatty acid storage and lipogenic proteins. PLoS One. 2012; 7(2):e31473. PMC: 3282778. DOI: 10.1371/journal.pone.0031473. View

12.

Christian C, Moenter S . The neurobiology of preovulatory and estradiol-induced gonadotropin-releasing hormone surges. Endocr Rev. 2010; 31(4):544-77. PMC: 3365847. DOI: 10.1210/er.2009-0023. View

13.

Zipf G, Chiappa M, Porter K, Ostchega Y, Lewis B, Dostal J . National health and nutrition examination survey: plan and operations, 1999-2010. Vital Health Stat 1. 2014; (56):1-37. View

14.

Khodamoradi K, Khosravizadeh Z, Seetharam D, Mallepalli S, Farber N, Arora H . The role of leptin and low testosterone in obesity. Int J Impot Res. 2022; 34(7):704-713. DOI: 10.1038/s41443-022-00534-y. View

15.

Rato Q . Conicity index: An anthropometric measure to be evaluated. Rev Port Cardiol. 2017; 36(5):365-366. DOI: 10.1016/j.repc.2017.02.003. View

16.

Amato M, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M . Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010; 33(4):920-2. PMC: 2845052. DOI: 10.2337/dc09-1825. View

17.

Georgiev I, Georgieva T, Ivanov V, Dimitrova S, Kanelov I, Vlaykova T . Effects of castration-induced visceral obesity and antioxidant treatment on lipid profile and insulin sensitivity in New Zealand white rabbits. Res Vet Sci. 2010; 90(2):196-204. DOI: 10.1016/j.rvsc.2010.05.023. View

18.

Kelly D, Jones T . Testosterone: a metabolic hormone in health and disease. J Endocrinol. 2013; 217(3):R25-45. DOI: 10.1530/JOE-12-0455. View

19.

Du Y, Feng R, Chang E, Yin L, Huang T, Li Y . Body mass index and body shape before treatment and nasopharyngeal carcinoma prognosis: A population-based patient cohort study in southern China. Int J Cancer. 2023; 153(2):290-301. DOI: 10.1002/ijc.34524. View

20.

Simental-Mendia L, Rodriguez-Moran M, Guerrero-Romero F . The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008; 6(4):299-304. DOI: 10.1089/met.2008.0034. View